sep
2018
Lecture Room 2421 Åke Göransson, Medicinarelängan, Medicinaregatan 11
A light lunch will be served from 11:15 outside the venue on a first come – first served basis. If you would like to contact the speaker, please e-mail the host, Associate Professor Silke Kern, silke.kern@neuro.gu.se.
About this seminar:
The speaker, Michelle M. Mielke, is a Professor of Epidemiology at the Department of Health Sciences Research and Professor of Neurology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN.
Dr. Mielke works as a translational epidemiologist to further understanding of the etiology and epidemiology of neurodegenerative diseases. A primary focus of her research is the identification of fluid biomarkers for the diagnosis, prediction, and progression of Alzheimer’s disease and other neurodegenerative diseases. Another focus of Dr. Mielke’s research is on understanding the sex and gender differences in the development and progression of neurodegenerative diseases. She directs the Mayo Clinic Specialized Center of Research Excellence on Sex Differences, with a specific focus on abrupt endocrine disruption, accelerated aging, and Alzheimer’s disease. Dr. Mielke is the chair of the Biofluid-Based Biomarker Professional Interest Area under the Alzheimer’s Association, co-Chair of the Society of Women’s Health Alzheimer’s Disease Network, a member of the Food and Drug Administration Peripheral and Central Nervous System Advisory Committee, and Senior Associate Editor of Alzheimer’s and Dementia. She is the PI of several NIH- and Foundation-funded clinical- and epidemiological-based grants. She has published over 200 manuscripts and has presented at multiple national and international conferences and consortiums.